- Home >
- Clinicals Trials >
- HR-NBL2
Childhood and adolescent cancers
HR-NBL2
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
- Open at Paris since : 10/07/2020
- Target : Child
- Phase : Phase III
Trial description
This is an international multicenter, open-label, randomized phase III trial including three sequential randomizations to assess efficacy of induction and consolidation chemotherapies and radiotherapy for patients with high-risk neuroblastoma.
Url of the trial